[Federal Register Volume 79, Number 37 (Tuesday, February 25, 2014)]
[Notices]
[Pages 10527-10528]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-04021]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day 14-0004]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to Leroy Richardson, 1600 Clifton Road NE., MS-D74, 
Atlanta, Georgia 30333; comments may also be sent by email to 
[email protected].
    Comments are invited on (a) whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have a practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarify of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of information technology. Written comments 
should be received within 60 days of this notice.

Proposed Project

    National Disease Surveillance Program II. Disease Summaries (0920-
0004 Exp. 8/31/2014)--Revision--National Center for Immunization and 
Respiratory Diseases, Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three year approval for a Revision of the National 
Disease Surveillance Program II. Disease Summaries information 
collection.
    Proposed revisions include shifting information collection 
management responsibilities to the National Center for Immunization and 
Respiratory Diseases (NCIRD) and consolidating various forms to reflect 
more current technology trends. Also, CDC requests the use of the 
following new Influenza forms to enhance surveillance and assist in 
understanding the complexities of these newer viruses: Human Infection 
with Novel Influenza A Virus Severe Outcomes; Human Infection with 
Novel Influenza A Virus with Suspected Avian Source; and Antiviral 
Resistant Influenza Infection Case Report Form.
    Due to the uncertainty regarding MERS-CoV and its threat to human 
health, CDC also has a need to use a Middle East Respiratory Syndrome 
Coronavirus (MERS-CoV) [Patient Under Investigation] form. Use of an 
Adenovirus Typing Report Form and discontinuing the use of the Harmful 
Algal Bloom-related Illness form is also requested. The Adenovirus 
Typing Report Form allows for a passive surveillance mechanism that 
collects adenovirus typing data to enhance adenovirus circulation data 
already collected by the National Respiratory and Enteric Virus 
Surveillance System (NREVSS).
    The methodology for reporting varies depending on the occurrence, 
modes of transmission, infectious agents, and epidemiologic measures.
    There is no cost to respondents other than their time.
    The total estimated annualized burden hours are 31,921.

                              Table 1--Estimated Annualized Burden Hours and Costs
----------------------------------------------------------------------------------------------------------------
    Type of respondents state epidemiologists                        Number of    Average burden
-------------------------------------------------    Number of     responses per   per response    Total burden
                    Form name                       respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Foodborne Outbreak Form (CDC 52.13).............              54              32           20/60             576
Influenza virus (Internet; year round) (CDC                   35              52           10/60             303
 55.31).........................................
-Influenza virus (electronic, year round)                     49              52            5/60             212
 (PHLIP)........................................
-Influenza virus (electronic, year round) (PHIN-               3              52            5/60              13
 MS)............................................
U.S. WHO Collaborating Laboratories Influenza                 87               1           10/60              15
 Testing Methods Assessment (CDC 55.31A)........
Weekly Influenza-like Illness (year round) (CDC            1,800              52           10/60          15,600
 55.20).........................................
Daily Influenza-like illness (year round).......              75             365           10/60           4,563

[[Page 10528]]

 
Influenza-Associated Pediatric Death Case Report              57               2           30/60              57
 Form...........................................
Novel Influenza A Virus Case Screening Form.....              57               1           15/60              14
Novel Influenza A Virus Infection Contact                     57               1           30/60              29
 Tracing Form...................................
Human Infection with Novel Influenza A Virus                  57               6           30/60             171
 Case Report Form...............................
Novel and Pandemic Influenza A Virus Case Status              57               1           15/60              14
 Summary........................................
Human Infection with Novel Influenza A Virus                  57               1             1.5              86
 Severe Outcomes................................
Human Infection with Novel Influenza A Virus                  57               1           30/60              29
 with Suspected Avian Source....................
122 CMRS--City health officers or vital                       58             365           12/60           4,234
 statistics registrars (daily)..................
122 CMRS--City health officers or vital                      122              52           12/60           1,269
 statistics registrars (weekly).................
Aggregate Hospitalization and Death Reporting                 56              52           10/60             485
 Activity Weekly Report Form....................
Antiviral Resistant Influenza Infection Case                  57               3           30/60              86
 Report Form....................................
National Enterovirus Surveillance Report: (CDC                25              12           15/60              75
 55.9) (electronic).............................
National Respiratory & Enteric Virus                         300              52           15/60           3,900
 Surveillance System (NREVSS) (CDC 55.83A, B,
 NREVSS Lab Assessment Form, D) (electronic)....
Adenovirus Typing Report Form...................              25              12           15/60              75
Middle East Respiratory Syndrome Coronavirus                  57               3           25/60              71
 (MERS) Patient Under Investigation (PUI) Form..
Suspected Viral Gastroenteritis (Calicivirus                  20               5           15/60              25
 surveillance)..................................
Waterborne Diseases Outbreak Form (CDC 52.12)...              57               1           20/60              19
                                                 ---------------------------------------------------------------
        Total...................................  ..............  ..............  ..............          31,921
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04021 Filed 2-24-14; 8:45 am]
BILLING CODE 4163-18-P